Very Severe Aplastic Anemia in a 26-Year-Old Male: Implications for Prognosis and Treatment Options

被引:0
作者
Alobaidi, Ahmed [1 ]
Albadry, Ahmed [2 ]
Murray, Anne [3 ]
机构
[1] Methodist Hlth Syst, Internal Med, Dallas, TX 75203 USA
[2] Charles Univ Prague, Fac Med, Prague, Czech Republic
[3] Methodist Hlth Syst, Clin Res Inst, Dallas, TX USA
关键词
pancytopenia; hematopoietic stem cell transplant; failure of the bone marrow; neutropenic fever; very severe aplastic anemia; BONE-MARROW-TRANSPLANTATION; OUTCOMES; CELLS;
D O I
10.7759/cureus.45750
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aplastic anemia (AA) is a hematopoietic stem cell (HSC) disorder characterized by the loss of HSCs, bone marrow failure, and peripheral pancytopenia. AA is classified as very severe (VSAA), severe (SAA), or nonsevere (NSAA) based on the severity criteria. This classification system has implications for the prognosis and treatment options offered to patients. The prognosis of AA has improved over the past several decades with the advancements in supportive care, HSC transplant (HCT), and immunosuppressive therapy (IST). In this report, we present the case of a 26 -year -old male diagnosed with VSAA after presenting with severe neutropenia and fever. The patient ultimately underwent HSC transplantation.
引用
收藏
页数:4
相关论文
共 17 条
  • [1] Increased apoptotic cells in bone marrow biopsies from patients with aplastic anaemia
    Callera, F
    Falcao, RP
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1997, 98 (01) : 18 - 20
  • [2] Immune-mediated bone marrow failure in C57BL/6 mice
    Chen, Jichun
    Desierto, Marie J.
    Feng, Xingmin
    Biancotto, Angelique
    Young, Neal S.
    [J]. EXPERIMENTAL HEMATOLOGY, 2015, 43 (04) : 256 - 267
  • [3] Approach to the diagnosis of aplastic anemia
    DeZern, Amy E.
    Churpek, Jane E.
    [J]. BLOOD ADVANCES, 2021, 5 (12) : 2660 - 2671
  • [4] DeZern AE, 2011, EXPERT REV HEMATOL, V4, P221, DOI [10.1586/ehm.11.11, 10.1586/EHM.11.11]
  • [5] Primary treatment of acquired aplastic anemia: Outcomes with bone marrow transplantation and immunosuppressive therapy
    Doney, K
    Leisenring, W
    Storb, R
    Appelbaum, FR
    [J]. ANNALS OF INTERNAL MEDICINE, 1997, 126 (02) : 107 - +
  • [6] Incidence of adult acquired severe aplastic anemia was not increased in Shanghai, China
    Fan, Rong
    Wang, Wei
    Wang, Xiao-Qin
    Lin, Guo-Wei
    [J]. ANNALS OF HEMATOLOGY, 2011, 90 (10) : 1239 - 1240
  • [7] Impact of age on outcomes after bone marrow transplantation for acquired aplastic anemia using HLA-matched sibling donors
    Gupta, Vikas
    Eapen, Mary
    Brazauskas, Ruta
    Carreras, Jeanette
    Aljurf, Mahmoud
    Gale, Robert Peter
    Hale, Gregory A.
    Ilhan, Osman
    Passweg, Jakob R.
    Ringden, Olle
    Sabloff, Mitchell
    Schrezenmeier, Hubert
    Socie, Gerard
    Marsh, Judith C. W.
    [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 (12): : 2119 - 2125
  • [8] Supportive care in severe and very severe aplastic anemia
    Hoechsmann, B.
    Moicean, A.
    Risitano, A.
    Ljungman, P.
    Schrezenmeier, H.
    [J]. BONE MARROW TRANSPLANTATION, 2013, 48 (02) : 168 - 173
  • [9] Biology and clinical management of hypoplastic MDS: MDS as a bone marrow failure syndrome
    Karantanos, Theodoros
    DeZern, Amy E.
    [J]. BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2021, 34 (02)
  • [10] Clinical course of non-severe aplastic anemia in adults
    Kwon, Ji Hyun
    Kim, Inho
    Lee, Yun Gyoo
    Koh, Youngil
    Park, Hayne Cho
    Song, Eun Young
    Kim, Hyun Kyung
    Yoon, Sung Soo
    Lee, Dong Soon
    Park, Sung Sup
    Shin, Hee Young
    Park, Seonyang
    Park, Myoung Hee
    Ahn, Hyo Seop
    Kim, Byoung-Kook
    [J]. INTERNATIONAL JOURNAL OF HEMATOLOGY, 2010, 91 (05) : 770 - 775